SGC AAK1 1 is primarily utilized in biochemical research, particularly in the study of kinase signaling pathways. It serves as a potent and selective inhibitor of Adaptor-Associated Kinase 1 (AAK1), which plays a crucial role in regulating endocytosis and cellular signaling processes. Researchers employ this compound to investigate the functional roles of AAK1 in various biological contexts, including neuronal signaling, immune response modulation, and cancer biology. Its application extends to the development of potential therapeutic strategies targeting AAK1-related disorders, such as neuropathic pain and certain types of cancer. Additionally, SGC AAK1 1 is a valuable tool for validating AAK1 as a drug target in preclinical studies.